By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
| Currency | US Dollars |
| Share Price | $ 129.11 |
| Closing Price Change | $ 4.97 |
| % Change | 0.00 % |
| 52 Week High | $133.10 |
| 52 Week Low | $92.92 |
| Volume | 0 |
| Shares Issued | 1,246.00m |
| RiskGrade | 120 |
| Strong Buy | 10 |
| Buy | 13 |
| Neutral | 5 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 29 |

| Time | Volume / Share Price |
| 10:56 | 100 @ $132.74 |
| 10:56 | 100 @ $132.72 |
| 10:56 | 103 @ $132.69 |
| 10:56 | 100 @ $132.72 |
| 10:56 | 200 @ $132.72 |
You are here: research